NEWS

eCapital significantly accelerates implementation of investment agreement with NanoGroup

eCapital, the main investor of NanoGroup S.A., on the earlier execution of the investment agreement and a much earlier payment of the remaining funds in the amount of PLN 3.25 million, despite the company not yet having achieved the next investment conditions – this is how Przemysław Mazurek, president of NanoGroup, says about the decision of the main investor. In September, eCapital also decided on another investment in the group of PLN 4.6 million at the current stock exchange rate.

The investment agreement between eCapital, founded by Michał Lach, and NanoGroup S.A. was concluded in March this year when the company’s share price was PLN 1.00 on the Stock Exchange. The total investment amounted to PLN 5.1 million, and the funds could be paid out in tranches after completing subsequent milestones (conditions), of which the group has so far completed two, including the key one, i.e. the successful autotransplantation of a pig kidney collected after a long, 30-minute stopped circulation using the NanOX system. According to the agreement, the investor could also take up shares of the new issue without waiting for the company to achieve subsequent milestones. Now, thanks to the investor’s decision to pay the remaining funds earlier, another PLN 3.25 million for the remaining stages has been transferred to the group’s account.

Investing in biotechnology is always associated with risk – the long and expensive development process, complicated regulations, and market competition can be discouraging. However, the profit potential in this industry is huge. That is why we are all the more pleased with the cooperation with Michał Lach and his company eCapital, our main investor. With such a partner who believes in our success and strategically supports our activities, we are sure that together we will face the challenges that await us. We are grateful for the trust and the decision to implement the investment agreement from March 2024 earlier, despite the implementation of only the first few conditions that we set for ourselves. This is not the end of our journey, but we can already see how much we can achieve thanks to this cooperation. This is an expression of great trust – says Przemysław Mazurek, CEO of NanoGroup S.A. and reminds us that this is another positive piece of news for NanoGroup recently. At the beginning of the week, eCapital announced another investment in the group at the level of PLN 4.6 million, at the current market share price of PLN 3.50.

At the same time, the group’s management assures that the investor’s decision will have only a positive impact on the adopted pace of work. This year, it is planned to file patent applications for the NanOX system, apply for EU funding, and also test a prototype of a device for storing organs collected for transplantation.

Prof. Tomasz Ciach

Founder, Member of the Management Board of NANOGROUP S.A.

Nanotechnology expert. Professor at the Faculty of Chemical and Processing Engineering, Warsaw University of Technology, head of the Biotechnology and Bioprocessing Division. Author of two technologies that are already in production stage, 12 granted patents and over 50 publications. Founder of BioMedLab research group, consultant in numerous companies (AstraZeneca, Procter and Gamble, Reckit, Adamed, Balton, Galmed). Work on various aspects of Biomedical Engineering, mostly on biomedical nanotechnology, active coatings for medical implants, nanoparticles for cancer treatment, biodegradable and nonbiodegradable implants, bone and vascular prosthesis. He gives rare, but already brilliant example of how brave ideas become socially and financially valuable.

Piotr Mierzejewski

Vice President of the Management Board of NANOGROUP S.A.

Clinical pharmacology specialist, former advisor to the Minister of Health on drug policy. He negotiated Poland’s accession to the EU in the field of pharmacy, responsible for the implementation of EU directives in the field of pharmacy into the Polish legal system. Co-founder of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Owner of a consulting company cooperating with international pharmaceutical companies in the field of introducing new technologies to the Polish market.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.

Przemysław Mazurek

President of the Management Board of NANOGROUP S.A.

Associated with the health market since 2004. As Managing Director, he restructured and developed the most dynamically operating Medical Center in the Podkarpacie region, creating and setting new standards of customer service quality on the market. Co-creator of the first solution in Poland for online registration of medical appointments. Co-founder of the first and only Infertility Treatment Clinic (MEDICOR) in Podkarpacie, which he headed as the President until 2009. He was responsible for the development of health insurance in the PZU Group. As Vice President of PZU Pomoc S.A. created the largest medical TPA in Poland to handle health insurance. Co-founder of the first drug insurance in Poland. Since 2015, he has been active in the field of Wealth Management and advises on management and finance. A graduate of International Economic and Political Relations as well as Management and Marketing at the Warsaw School of Economics.